Depo-Provera Settlement

Pfizer and plaintiffs’ attorneys announced a settlement in June 2026 and signed a settlement agreement in July. The agreement is intended to resolve a majority of claims in the federal multidistrict litigation and New York state court.

According to the July court order, the about 80% of the cases in the Depo shot multidistrict litigation could be eligible for the settlement. Eligibility is governed by the settlement agreement, which is confidential.

Thousands of women filed Depo-Provera lawsuits claiming the contraceptive injection is tied to the development of meningiomas, a typically benign but potentially serious type of tumor in the lining of the brain. 

The settlement agreement came much faster than is often common for dangerous product litigations like this one. It can sometimes take years and multiple trials before an agreement is reached.

The earliest Depo shot lawsuits were filed in late 2024 after a study published in the BMJ found that people who took the birth control shot could be upwards of five times more likely to develop a meningioma. None of these cases has advanced to trial yet.

In light of the settlement news, an early trial scheduled for December 2026 was removed from the calendar. The deal is now being finalized as new cases continue to pour in. More than 3,000 new Depo-Provera lawsuits were filed in the first half of 2026 alone. Eligible claimants must register for the settlement program by Nov. 30, 2026. In the meantime, lawyers are continuing to accept and file new cases for people who could be eligible for compensation.

The public court orders reviewed do not disclose an average Depo-Provera settlement amount, individual awards or a formula for calculating compensation so there isn’t an average settlement amount per claim. Some members of the legal industry have estimated that the payout for an individual Depo-Provera settlement could range from $75,000 to $1.5 million or more. But these amounts are just speculative and should not be treated as confirmed payouts under the signed agreement.

The settlement is private, and its eligibility and compensation terms should be discussed with your attorney.

In dangerous product litigations, the strongest cases typically receive the largest payouts. This can include cases with the most severe injuries or the most compelling evidence. In the Depo-Provera litigation, that may mean cases in which meningiomas caused severe, life-altering symptoms.

When Could Depo-Provera Settlement Payments Begin?

In July 2026, the parties told the court that settlement payments were expected to begin rolling out by the first quarter of 2027. But this was a projected timeline, not a guaranteed payment date for every claimant. Ask your attorney for the current status of your claim.

Eligibility terms for the Depo-Provera settlement have not yet been disclosed. The criteria for qualification will likely be revealed after that agreement is finalized.

While we’re still waiting to learn more about the Depo shot settlement, many agreements for dangerous product lawsuits do not distribute payouts equally. Individual cases may qualify for different levels of compensation.

To qualify for a lawsuit, you typically need a meningioma diagnosis after using Depo-Provera for at least a year. Women who received a generic version of the drug or Depo-subQ Provera 104 (a lower-dose version) may also qualify.

Drugwatch’s free case evaluation can help you see if you’re eligible for a Depo-Provera lawsuit.